Navigation Links
Advanced Prostate Cancer Drug May Help at Earlier Stage

surgery. Nor has the surgery, which removes the entire prostate.

Zytiga blocks production of testosterone, which can promote the growth of prostate cancer cells, but in a different way than established hormonal treatments.

This small, phase 2 trial involved 56 men with an average age of 58, all of whom had had at least three positive biopsies for prostate cancer.

For the first three months, 27 men received the standard hormonal therapy leuprolide alone, followed by leuprolide plus Zytiga for another three months.

The remaining 29 men received the two-drug combination for the whole six months, after which all men in both groups underwent prostate surgery.

One-third of the men who had received leuprolide plus Zytiga for the entire six months saw complete or nearly complete elimination of their cancer.

By comparison, only 15 percent of men in the other group experienced these results, the investigators found.

Those who received the combination for only 12 weeks had much lower response rates.

The participants also received low doses of the steroid prednisone to prevent side effects from Zytiga, although side effects overall were minimal, said Taplin.

It's not clear at this point why some men responded to the combination therapy while others did not, and that is an area that needs to be studied, the researchers said.

"In highly select people who have this aggressive type of prostate cancer, I think this is an important area to investigate," Brooks noted. "We need to figure out which patients would potentially benefit."

According to study author Taplin, the research received some funding from Johnson & Johnson, the maker of Zytiga. She said the drug is currently U.S. Food and Drug Administration-approved for patients with advanced prostate cancer that does not respond to hormone therapy, and costs about $5,000 per month.

The data and conclusions of research presented at medical meet

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Advanced genetic screening method may speed vaccine development
2. Experimental Gel May Help Those With Advanced Parkinsons
3. CYFRA21-1 might be predictive marker in advanced NSCLC
4. Womans Recovery From Advanced Melanoma Could Help Guide Research
5. Study shows advance in using patients own tumor-fighting cells to knock back advanced melanoma
6. Canadian scientist develops worlds most advanced drug to protect the brain after a stroke
7. Study finds injectable treatment for blood clots in advanced cancer patients increases
8. Fogarty Institute for Innovation launches advanced endovascular training fellowship
9. Experimental Drugs Do Battle Against Advanced Prostate Cancer
10. Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
11. RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer
Post Your Comments:
Related Image:
Advanced Prostate Cancer Drug May  Help at Earlier Stage
(Date:8/30/2014)... In today’s world, a good night’s sleep has ... and sleep apnea (a medical problem where the airway ... their bed partners of the rest they need to ... population snores and 20 million people in the United ... have been diagnosed and treated; and of those treated, ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The new review ... program was created by Karen Brimeyer, who wanted to make ... , This guide is now easy to find in ... download. In this guide, the author of the new method ... , Daily Gossip writes in its review that the ...
(Date:8/30/2014)... August 30, 2014, a company dedicated ... other healthy lifestyle resources, is proud to announce it has ... for at home fitness solutions by ABC’s Good Morning America. ... story on ABC’s Good Morning America, “Live Streaming Fitness is ... streamline your day by streamlining your workout…to boot camp at ...
(Date:8/30/2014)... York, NY (PRWEB) August 30, 2014 When ... will quickly ensue, as happened on Wednesday, August 27th, when ... successful attack on JPMorgan Chase & Co and at ... the FBI is actually investigating attacks on seven prominent ... how they may be affected, and the buzz quickly goes ...
(Date:8/30/2014)... Viejo, California (PRWEB) August 30, 2014 ... announced the release of the TransGhost plugin from Pixel ... tool that gives users the ability to tell their ... CEO of Pixel Film Studios. “Users will make their ... use transition plugin.” , With TransGhost users can awaken ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health is New Trend In Fitness 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 3
... long-term investment and social responsibility in industry categoryMADISON, N.J., ... DGX ), the world,s leading provider of diagnostic testing, ... magazine,s list of the World,s Most Admired Companies. Quest ... "Pharmacy and Other Services." The 2009 ranking is the ...
... long-term care insurance. , ... Newark, NJ (PRWEB) March 3, 2009 -- ... you off, Prudential has a way out the maze. Prudential ... confuse the decision-making process., , , , ,Although its design is simpler, ...
... as One of the World,s Most Admired CompaniesEL SEGUNDO, ... of kidney care services, today accepted the honor by ... health care facilities in the country. DaVita(R) ranked #1 ... innovation, Long-Term Investment and Quality of Products and Services. ...
... Cantel Medical Corp. (NYSE: CMN ) will ... its second quarter ended January 31, 2009 on March 9, ... will be Charles M. Diker, Chairman; Andrew A. Krakauer, President; ... K. Malkin, President of Minntech Corporation. Minntech is a Cantel ...
... American Life League launched a campaign today to ... Human Services Secretary, Gov. Kathleen Sebelius.(Logo: ... Sebelius, disturbing and radical record of promoting abortion ... Life League. "Sebelius, governor of Kansas - the ...
... Welcome to Consumer Reports Health News for health ... cover issues pertaining to the efficacy and safety ... mental health, diet and nutrition, food safety, and ... rates the effectiveness and affordability of prescription drugs, ...
Cached Medicine News:Health News:Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List 2Health News:Prudential Long-Term Care Product Simplifies Decisions 2Health News:Prudential Long-Term Care Product Simplifies Decisions 3Health News:FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality 2Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2009 2Health News:A.L.L. Launches 'Stop Sebelius' Campaign 2Health News:Consumer Reports Health News 2Health News:Consumer Reports Health News 3
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)...   Vittamed Corporation , a neurodiagnostics medical device company ... T. (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, ... " Teo Forcht Dagi is an ... and venture capital," said Remis Bistras , President and ... clinical, strategic, and entrepreneurial expertise to our Board." ...
(Date:8/29/2014)... 2014 Research and Markets has ... Drugs Market 2014-2018" report to their offering. ... condition that results in demyelination, axonal transection, and neurodegeneration. ... response by the immune system, which targets neurons within ... debilitating disease in which the damage of the myelin ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... LAKE, N.J. , May 10 Par Pharmaceutical ... its partner, Glenmark Generics Limited and Glenmark Generics Inc., ... & Co. Inc. that resolves patent litigation related to Glenmark,s ... ends the lawsuit involving a challenge by Glenmark which sought ...
... , May 10 /PRNewswire-Asia/ -- On April ... cases with Beijing Un-Assegai Technical &,Trade Co. Ltd. (hereinafter referred ... China , as claimant and U.S. Abbott,Laboratories (Abbott U.S.; ... by the,China International Economic and Trade Arbitration Commission (CIETAC), which,has ...
Cached Medicine Technology:Par's Development and Marketing Partner, Glenmark, Enters Into A Settlement Agreement With Merck To Settle Patent Litigation Over Generic ZETIA(R) 2Assegai Wins Big Settlement Against ABBOTT's Subsidiary 2